ORYZON GENOMICS - 1H - Technical analysis published on 04/23/2025 (GMT)
- 89
- 0
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Additional analysis
Quotes
The ORYZON GENOMICS rating is 3.135 EUR. On the day, this instrument gained +7.55% with the lowest point at 2.885 EUR and the highest point at 3.135 EUR. The deviation from the price is +8.67% for the low point and 0% for the high point.The Central Gaps scanner detects the formation of a bullish gap marking the strong presence of buyers against sellers at the opening. This formed a quotation gap.
Opening Gap UP
Type : Bullish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by ORYZON GENOMICS:
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
A technical analysis in 1H of this ORYZON GENOMICS chart shows a strongly bullish trend. 89.29% of the signals given by moving averages are bullish. The overall trend is supported by the strong bullish signals from short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, 17 technical indicators on 18 studied are currently positioned bullish. Caution: the Central Indicators scanner currently detects an excess:
RSI indicator is overbought : over 80
Type : Neutral
Timeframe : 1 hour
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : 1 hour
Previous candle closed over Bollinger bands
Type : Neutral
Timeframe : 1 hour
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 2 (Daily)
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 3 (Daily)
Type : Neutral
Timeframe : Weekly
Pivot points : price is over resistance 3 (Weekly)
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 3 (Monthly)
Type : Neutral
Timeframe : 1 hour
The Central Patterns scanner, which studies chart patterns, resistances and supports, has identified these signals:
Near horizontal resistance
Type : Bearish
Timeframe : 1 hour
Resistance of channel is broken
Type : Bullish
Timeframe : 1 hour
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 2.669 | 2.888 | 3.090 | 3.135 | 3.260 | 3.380 | 3.643 |
Change (%) | -14.86% | -7.88% | -1.44% | - | +3.99% | +7.81% | +16.20% |
Change | -0.466 | -0.247 | -0.045 | - | +0.125 | +0.245 | +0.508 |
Level | Intermediate | Major | Minor | - | Major | Intermediate | Major |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 2.617 | 2.678 | 2.797 | 2.858 | 2.977 | 3.038 | 3.157 |
Camarilla | 2.866 | 2.882 | 2.899 | 2.915 | 2.932 | 2.948 | 2.965 |
Woodie | 2.645 | 2.693 | 2.825 | 2.873 | 3.005 | 3.053 | 3.185 |
Fibonacci | 2.678 | 2.747 | 2.790 | 2.858 | 2.927 | 2.970 | 3.038 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 2.500 | 2.585 | 2.660 | 2.745 | 2.820 | 2.905 | 2.980 |
Camarilla | 2.691 | 2.706 | 2.720 | 2.735 | 2.750 | 2.764 | 2.779 |
Woodie | 2.495 | 2.583 | 2.655 | 2.743 | 2.815 | 2.903 | 2.975 |
Fibonacci | 2.585 | 2.646 | 2.684 | 2.745 | 2.806 | 2.844 | 2.905 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 1.350 | 1.910 | 2.550 | 3.110 | 3.750 | 4.310 | 4.950 |
Camarilla | 2.860 | 2.970 | 3.080 | 3.190 | 3.300 | 3.410 | 3.520 |
Woodie | 1.390 | 1.930 | 2.590 | 3.130 | 3.790 | 4.330 | 4.990 |
Fibonacci | 1.910 | 2.368 | 2.652 | 3.110 | 3.568 | 3.852 | 4.310 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
RSI (14): | 84.96 | |
MACD (12,26,9): | 0.0670 | |
Directional Movement: | 36.243 | |
AROON (14): | 92.857 | |
DEMA (21): | 2.934 | |
Parabolic SAR (0,02-0,02-0,2): | 2.843 | |
Elder Ray (13): | 0.173 | |
Super Trend (3,10): | 2.900 | |
Zig ZAG (10): | 3.095 | |
VORTEX (21): | 1.2500 | |
Stochastique (14,3,5): | 93.16 | |
TEMA (21): | 2.995 | |
Williams %R (14): | -1.28 | |
Chande Momentum Oscillator (20): | 0.360 | |
Repulse (5,40,3): | 5.5700 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.1590 | |
Courbe Coppock: | 15.70 |
MA7: | 2.823 | |
MA20: | 2.901 | |
MA50: | 2.759 | |
MA100: | 2.131 | |
MAexp7: | 2.965 | |
MAexp20: | 2.862 | |
MAexp50: | 2.810 | |
MAexp100: | 2.823 | |
Price / MA7: | +11.05% | |
Price / MA20: | +8.07% | |
Price / MA50: | +13.63% | |
Price / MA100: | +47.11% | |
Price / MAexp7: | +5.73% | |
Price / MAexp20: | +9.54% | |
Price / MAexp50: | +11.57% | |
Price / MAexp100: | +11.05% |
News
Don't forget to follow the news on ORYZON GENOMICS. At the time of publication of this analysis, the latest news was as follows:
- ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
- ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
- ORYZON to Provide Corporate Progress Updates at Several Events in March-April
- Oryzon Announces Publication of Study on Phelan-McDermid Syndrome (PMS) Patients, a Form of Autism, Paving the Way for a Novel Personalized Medicine Approach with Vafidemstat
- Oryzon Defines Phase III Trial Endpoints for Agitation and Aggression in BPD with Input From New Clinical Advisory Board
Add a comment
Comments
0 comments on the analysis ORYZON GENOMICS - 1H